APA

Yoshida M., Sawada T., Ishii H., Gerszten R. E., Rosenzweig A., Gimbrone M. A., Yasukochi Y. & Numano F. (20010913). Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

Yoshida M, Sawada T, Ishii H, Gerszten R E, Rosenzweig A, Gimbrone M A, Yasukochi Y and Numano F. 20010913. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

Yoshida M., Sawada T., Ishii H., Gerszten R. E., Rosenzweig A., Gimbrone M. A., Yasukochi Y. and Numano F. (20010913). Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

Yoshida M, Sawada T, Ishii H, Gerszten R E, Rosenzweig A, Gimbrone M A, Yasukochi Y and Numano F. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. : Arteriosclerosis, thrombosis, and vascular biology. 20010913.